Advertisement
U.S. Markets open in 2 hrs 35 mins

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.5400-0.7600 (-14.34%)
At close: 04:00PM EST
4.5000 -0.04 (-0.88%)
Pre-Market: 04:22AM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
0
0
Operating Expense
12,916
10,521
13,158
11,498
11,502
Operating Income
-12,916
-10,521
-13,158
-11,498
-11,502
Net Non Operating Interest Income Expense
-
-
-
0
-232.426
Other Income Expense
-78.405
460.485
-21.533
267.055
8.842
Pretax Income
-12,994
-10,060
-13,179
-11,231
-11,726
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-12,994
-10,060
-13,179
-11,352
-12,121
Diluted NI Available to Com Stockholders
-12,994
-10,060
-13,179
-11,352
-12,121
Basic EPS
-2.56
-79.00
-228.00
-280.00
-630.00
Diluted EPS
-2.56
-79.00
-228.00
-280.00
-630.00
Basic Average Shares
5,014
127.275
57.825
40.922
19.192
Diluted Average Shares
5,014
127.275
57.825
40.922
19.192
Total Operating Income as Reported
-12,916
-10,521
-13,158
-11,498
-11,502
Total Expenses
12,916
10,521
13,158
11,498
11,502
Net Income from Continuing & Discontinued Operation
-12,994
-10,060
-13,179
-11,231
-11,726
Normalized Income
-12,994
-10,060
-13,179
-11,540
-11,726
Interest Expense
-
-
-
0
232.426
Net Interest Income
-
-
-
0
-232.426
EBIT
-12,649
-10,521
-13,158
-11,498
-11,493
EBITDA
-12,429
-10,245
-12,923
-11,274
-11,328
Reconciled Cost of Revenue
-
-
-
-
-
Reconciled Depreciation
220.159
275.451
234.258
224.415
165.249
Net Income from Continuing Operation Net Minority Interest
-12,994
-10,060
-13,179
-11,231
-11,726
Total Unusual Items Excluding Goodwill
0
-
0
308.6
0
Total Unusual Items
0
-
0
308.6
0
Normalized EBITDA
-12,429
-10,245
-12,923
-11,582
-11,328
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0